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ClC-2 is a plasma membrane chloride channel with widespread expression in the human body, 
including the brain. Its function is still being studied, although it is thought to have a role in ion and 
water homoeostasis in the brain. ClC-2 is part of a complex containing GlialCAM and MLC1. Both 
these genes are associated with autosomal recessive human leukodystrophies with intramyelinic edema. 
Biallelic mutations in CLCN2, encoding the ClC-2 channel, have been reported in patients with a rare 
form of LeuKoencePhalopathy with Ataxia (LKPAT; MIM # 615651). No peculiar neurological 
features have been reported for this disease, although slight visual impairment due to chorioretinopathy 
or optic atrophy, mild ataxia, learning disabilities and headaches are recurrent symptoms in patients. 
However, MRI shows a typical diagnostic pattern that consists of white matter signal abnormalities in 
the posterior limbs of the internal capsules, cerebral peduncles, pontine pyramidal tracts and in the 
middle cerebellar peduncles, associated with lower Apparent Diffusion Coefficient (ADC) values in 
most cases. Specific anomalies of Brainstem Auditory Evoked Potentials (BAEP) have also been 
described [1-3]. 
Here, we report on a 52 year-old Moroccan woman presenting with mild and asymptomatic 
bilateral optic atrophy detected at a routine ophthalmological examination for presbyopia. Best-
corrected high-contrast visual acuity was 20/20 in both eyes. Anterior segment and intraocular 
pressures were normal, and pupillary reflexes were present. Upon fundus biomicroscopy, mild pallor 
and excavation of the optic disc were evident in both eyes. Moreover, in her left eye, myelinated retinal 
nerve fibers were present, while her right eye was normal (Figure 1). No alterations were evident upon 
examination with optical coherence tomography (Supplementary Figure 1) or fundus autofluorescence 
in either eye. A chronic simple glaucoma and retinal vessel pathology were excluded. Her familial and 
personal clinical history was unremarkable, apart from a moderate headache, and blood exams were 
normal. The neurological examination was normal except for bilateral mild optic disc pallor at 
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funduscopy (Figure 1). At the neurophysiological study, a normal latency and amplitude of the visual 
evoked potential (VEP) responses were documented, while BAEPs were characterized by a marked 
increase in the III-V interval, representative of ponto-mesencephalic conduction time, a normal latency 
of I wave, normal I-III interval values, and V wave amplitude (Supplementary Figure 2). MRI 
displayed an unusual pattern of symmetrical white matter anomalies suggestive of LKPAT (Figure 1A). 
Post contrast MRI did not demonstrate any enhancement. 
Informed consent was obtained from the patient, and the Internal Review Board committee of 
the Department of Medical Sciences (University of Turin) approved this study. We analyzed all coding 
exons and flanking intron boundaries of CLCN2 (NM_004366) by PCR amplification of blood-
extracted genomic DNA (Qiagen, Mannheim, Germany; conditions available upon request), followed 
by Sanger sequencing (Life Technologies, Carlsbad, CA, USA). We identified the homozygous 
c.1769A>C (p.His590Pro) missense variant in exon 16 (Figure 1B). This change was not reported in 
any genetic database (ExAC v.0.3.1, dbSNPs147), and was shown to affect a highly conserved residue 
(Figure 1C), predicted to be pathogenic based on bioinformatics analyses (SIFT, PolyPhen2, I-Mutant, 
Mutation taster, PHD-SNP, SNAP-F; Table 1). To ascertain the role of this mutation on the protein, we 
compared the subcellular localization of the wild type and mutated ClC-2 protein after transient 
transfection of VERO cells with the V5-His6-tagged ClC-2 expression plasmid [1]. We demonstrated 
that the p.His590Pro ClC-2 protein barely reaches the plasma membrane and accumulates within the 
endoplasmic reticulum, with a pattern similar to the positive control plasmid carrying the known 
pathogenic p.Ala500Val variant (Figure 1D) [1]. These in vitro findings corroborate a pathogenic role 
for the p.His590Pro missense change.  
There have only been eight LKPAT patients described in the literature (Supplementary Table 2). 
Depienne et al. reported six unrelated cases with homozygous or compound heterozygous mutations in 
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the CLCN2 gene [1]. A subclinical form of leukodystrophy associated with infertility was also reported 
in a man with a novel homozygous CLCN2 mutation [2]. More recently, Hanagasi et al. described a 22 
year-old woman with paroxysmal kinesigenic dyskinesia due to a homozygous CLCN2 mutation [3]. 
Our case resembles other LKPAT cases, characterized by a very mild clinical phenotype despite a clear 
MRI abnormality involving the pyramidal tracts. This clinical/radiological discrepancy suggests that 
white matter anomalies could cause intramyelinic edema, which does not impair the axonal function. 
Conversely, the compromised chloride channel function may be harmful for the visual and auditory 
systems, as suggested by the optic atrophy and the BAEP anomalies found in our patient, as well as in 
the animal model of the disease [4]. The animal model displays a “pure” slowing conduction with 
preservation of the synchronous activation of potential generators. This pattern is distinct from those 
observed in the vast majority of genetic or acquired myelin pathologies in which slowing conduction 
and potential dispersion occur concomitantly. Moreover, myelin disorders are usually characterized by 
a prevalent slowing conduction in the I-III interval, both in murine models of myelination defects [5] 
and in human leukodystrophies. 
However, a selective increase in the III-V interval is far more common in acquired disorders that 
determine a brainstem focal lesion. 
In conclusion, we report on a novel case of subclinical leukodystrophy associated with CLCN2 
mutations. Our case confirms the extreme variable clinical presentation of LKPAT and emphasizes the 
importance of recognizing specific MRI patterns as a guidance to genetic tests in adult 
leukoencephalopathies. 
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Figure legends 
Figure 1. MRI, molecular and in vitro analyses.  
Panel A: MRI abnormalities. FLAIR (1-3) and DWI (4-6) images show hyperintensity of the 
pyramidal tracts in the posterior limbs of internal capsules (arrowheads in 1, 4), midbrain cerebral 
peduncles (arrowheads in 2, 5), and middle cerebellar peduncles and pons (light green and light blue 
arrowheads, respectively, in 3, 6). No restriction at the ADC map was present (7-9). Panel B: fundus 
biomicroscopy signs. Mild pallor and excavation of the optic disc in both eyes (L and R) and 
myelinated retinal nerve fibers in the left eye (L). Panel C: molecular analysis. The p.His590Pro 
change is shown. Panel D: in vitro studies. Subcellular localization of the ClC-2 wild type (WT), 
p.Ala500Val (with a known pathogenic change [1]) and p.His590Pro variant proteins is shown (green). 
A marker of the endoplasmic reticulum (anti-calreticulin, red) was used to verify co-localization by 
confocal microscopy. Note that wild type ClC-2 protein typically reaches the plasma membrane, 
whereas both the ClC-2(p.Ala500Val) and ClC-2(p.His590Pro) proteins are retained in the endoplasmic 
reticulum. A 10X inset is shown. Scale bar = 25 µM.  
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Supplements 
Supplementary Figure 1: optical coherence tomography. 
Right Eye: no alteration 
 
Left Eye: no alteration 
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Supplementary Figure 2: BAEP and VEP findings. 
BAEP: marked increase in the III-V interval 
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VEP: normal and symmetrical (P100) latency and amplitude. 
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Supplementary Table 1. In silico prediction of variant pathogenicity and the evolutionary conservation among 
mammals of the histidine 590 residue using the “Multiz Alignment of 100 Vertebrates” track of the UCSC 
genome browser (www.genome.ucsc.edu) 
 
 
 
 
 
 
 
 
 
 
 
 
Software Information Description Value output Bibliography 
SIFT Pathogenic or not predictor damaging 0 Ng and Henikoff (2001) 
PolyPhen-2 Pathogenic or not predictor Possibly damaging 0.77 Adzhubei IA et al. (2010) 
I-Mutant Stability changes predictor Increase stability -0.01 Capriotti et al. (2005) 
Mutation Taster Pathogenic or not predictor damaging 0.97 Schwarz et al. (2014) 
SNAP-F Pathogenic or not predictor Non-neutral 3 Bromberg and Rost (2007) 
PHD-SNP Pathogenic or not predictor Disease 5 Capriotti et al. (2006) 
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Supplementary Table 2:  LKPAT patients described in the literature. 
 
 Depienne et al., 
2013 (1) 
Depienne et al., 
2013 (2) 
Depienne et al., 
2013 (3) 
Depienne et 
al., 2013 (4) 
Depienne et al., 
2013 (5) 
Depienne et al., 
2013 (6) 
Di Bella et al., 
2014 
Hanagasi et al., 
2015 
Our patient 
Gender/ 
ancestry 
F/North Africa F/North Africa F/North Africa F/Europe M/Europe F/Europe M/Europe F/Middle East F/ North Africa 
Age at first 
neurological 
sign 
44 yrs. 57 yrs. 30 yrs. 12 yrs. 6 yrs. 3 yrs. 42 yrs. 7 yrs. 52 yrs. 
Symptom at 
onset 
Action tremor 
Mild gait ataxia  
Tinnitus 
Vertigo 
Chorioretinopathy 
Psychosis 
Learning 
disability 
Headache 
Headache Action tremor 
Mild gait ataxia  
Postural hand 
tremor 
Palmomental 
reflex        
Increased deep 
tendon reflexes 
Bilateral Hoffman 
sign 
Mild bilateral hand 
tremor 
Presbiopia 
Headache 
Disease 
course 
Stable Progressive Stable Stable Stable Stable Stepwise Stable Stable 
Vision Normal 20/80 RE 
20/400 LE 
1/10 RE 
1/50 LE 
Normal with 
glasses 
Normal with 
glasses  
Strabismus 
Normal Normal Normal Presbyopia 
Fundoscopy 
and optic 
nerve 
Normal Retinoschisis 
Bilateral optic 
neuropathy 
Retinal atrophy 
Choroidal 
neovascularisation 
Bilateral optic 
neuropathy 
Normal Normal Normal Normal Normal Bilateral mild 
pallor and 
excavation of the 
optic disc 
Myelinated retinal 
nerve fibers in left 
eye 
Hearing Normal Perceptive 
hearing loss 
Normal Normal Normal Normal Normal Normal Normal 
Pyramidal No No No Mild spasticity No Mild spasticity Increased deep 
tendon reflexes 
Bilateral Hoffman 
No No 
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signs sign 
Cerebellar 
signs 
Mild ataxia Mild ataxia Mild ataxia Mild ataxia Mild ataxia 
Nystagmus 
Mild ataxia Postural hand 
tremor 
Mild dismetria 
Dysdiadochokinesia 
no 
Other 
neurological 
signs 
            Palmomental 
reflex 
Paroxysmal 
kinesigenic 
dyskinesia 
  
Headhache No No Yes Severe Severe No No No Mild 
Other             Azoospermia     
 
 
 
 
 
 
